阿科力(603722.SH):控股股東方面減持期屆滿 合計減持179.25萬股
格隆匯6月15日丨阿科力(603722.SH)公佈,截至2021年6月15日,公司控股股東、實際控制人朱學軍及其一致行動人崔小麗此次減持時間區間屆滿,朱學軍通過大宗交易方式累計減持公司股份151萬股,約佔公司總股本的1.72%;崔小麗通過集中競價方式累計減持公司股份28.25萬股,約佔公司總股本的0.32%。
朱學軍當前持有公司股份2279萬股,佔公司總股本的25.92%;崔小麗當前持有公司股份971.75萬股,佔公司總股本的11.05%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.